Yu Fan Diversified Active

Location: Central, Hong Kong, Hong Kong

CIK: 0001668029 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: Sep 17, 2021

Total Value: $38.31M (100.0% shares, 0.0% debt)

Holdings (5)

AVIR ATEA PHARMACEUTICALS INC 48.4%

Value $18.52M Shares 300,000 Est. Cost $32.23 Unrealized +109.6%

LUNG PULMONX CORP 36.2%

Value $13.86M Shares 303,030 Est. Cost $48.97 Unrealized +17.1%

— ABG ACQUISITION CORP I 12.9%

Value $4.958M Shares 501,300 Est. Cost $9.89 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 2.3%

Value $887K Shares 112,044 Est. Cost $7.87 Unrealized —

— DIFFUSION PHARMACEUTICALS IN 0.2%

Value $82,000 Shares 89,848 Est. Cost $0.79 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AVIR	ATEA PHARMACEUTICALS INC	300,000	$18.52M	48.4%	$32.23	+109.6%	COM	04683R106
LUNG	PULMONX CORP	303,030	$13.86M	36.2%	$48.97	+17.1%	COM	745848101
—	ABG ACQUISITION CORP I	501,300	$4.958M	12.9%	$9.89	—	CL A SHS	G00496102
—	AEGLEA BIOTHERAPEUTICS INC	112,044	$887K	2.3%	$7.87	—	COM	00773J103
—	DIFFUSION PHARMACEUTICALS IN	89,848	$82,000	0.2%	$0.79	—	COM PAR	253748305